↓ Skip to main content

Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study

Overview of attention for article published in Cardiovascular Toxicology, December 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
6 patents

Citations

dimensions_citation
79 Dimensions

Readers on

mendeley
98 Mendeley
Title
Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study
Published in
Cardiovascular Toxicology, December 2014
DOI 10.1007/s12012-014-9297-4
Pubmed ID
Authors

Richard J. Kovacs, Giuliana Maldonado, Analia Azaro, Maria S. Fernández, Federico L. Romero, Juan M. Sepulveda-Sánchez, Mary Corretti, Michael Carducci, Melda Dolan, Ivelina Gueorguieva, Ann L. Cleverly, N. Sokalingum Pillay, Jose Baselga, Michael M. Lahn

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
Unknown 97 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 21%
Student > Ph. D. Student 13 13%
Student > Master 11 11%
Student > Bachelor 9 9%
Other 9 9%
Other 14 14%
Unknown 21 21%
Readers by discipline Count As %
Medicine and Dentistry 28 29%
Biochemistry, Genetics and Molecular Biology 16 16%
Agricultural and Biological Sciences 10 10%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Nursing and Health Professions 5 5%
Other 13 13%
Unknown 21 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 January 2022.
All research outputs
#7,531,132
of 22,979,862 outputs
Outputs from Cardiovascular Toxicology
#52
of 280 outputs
Outputs of similar age
#108,713
of 362,314 outputs
Outputs of similar age from Cardiovascular Toxicology
#3
of 5 outputs
Altmetric has tracked 22,979,862 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 280 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,314 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.